Cigna Group Delivers Strong Q1 Performance, Announces Leadership Change and Strategic Portfolio Moves

Cigna Posts Impressive First Quarter Results

The Cigna Group (NYSE:CI) kicked off 2026 with robust financial performance, delivering first-quarter revenues of $68.5 billion and adjusted earnings per share of $7.79. The healthcare giant's results prompted management to boost its full-year earnings guidance while unveiling significant strategic changes ahead.

CFO Ann Dennison highlighted the quarter's strength, noting 16% year-over-year growth in adjusted earnings per share. The performance exceeded internal expectations across multiple business segments, leading to an upward revision of the company's 2026 outlook.

Raised Guidance Reflects Strong Momentum

Based on the solid first-quarter showing, Chairman and CEO David Cordani announced the company is increasing its full-year 2026 adjusted EPS outlook to at least $30.35. Dennison characterized the updated forecast as reflecting "positive momentum in our businesses while maintaining a prudent view of the current environment."

The quarter included after-tax special items charges of $322 million, equivalent to $1.22 per share, as noted by Investor Relations SVP Ralph Giacobbe.

Major Leadership Transition Approaching

A significant corporate milestone approaches as Cordani announced this would mark his final quarterly earnings call as CEO. The planned leadership transition takes effect July 1, when President and COO Brian Evanko will assume the CEO role while Cordani transitions to executive chair.

Evanko outlined his strategic vision for the company, emphasizing plans to position Cigna as "the clear leader in consumer-focused and AI-enabled health services, with an emphasis on clinically complex patients." His objectives center on making healthcare "more affordable and more personalized" for customers.

Strategic Portfolio Adjustments Announced

Evanko revealed two major portfolio decisions during the call. First, Cigna plans to exit its individual exchange business by the end of 2026, describing it as a "thoughtful sunsetting" designed to ensure member continuity. He emphasized that "there are no changes to coverage or networks related to this announcement," with the company committed to supporting members through open enrollment transitions into 2027.

The second strategic move involves initiating a comprehensive review of alternatives for EviCore, the company's care review and prior authorization services business. Evanko connected this review to broader industry trends toward standardization and automation in prior authorization processes, stating the company will "explore options" to maintain service levels while "maximizing long-term value."

During the Q&A session, Evanko clarified both decisions were proactive moves rather than responses to external approaches. He cited the exchange business's lack of a "clear path to scale" and management's desire to refocus resources as primary drivers.

Business Segment Performance Analysis

Evernorth, Cigna's health services arm, demonstrated mixed results in the first quarter. Revenues climbed 9% to $58.4 billion, while pre-tax adjusted earnings grew 2% to $1.5 billion, slightly exceeding expectations.

Within Evernorth, Specialty and Care Services showed particular strength with pre-tax adjusted earnings jumping 20% to $1.1 billion. Dennison attributed this growth to solid specialty volume increases, a favorable mix shift toward biosimilars and specialty generics, and contributions from Shields Health Solutions.

Conversely, Pharmacy Benefit Services (PBS) experienced a 28% decline in pre-tax adjusted earnings to $394 million, though this aligned with management expectations due to previously discussed client contract renewals and investments in the Signature rebate-free model.

Healthcare Division Shows Strong Results

Cigna Healthcare delivered robust performance with first-quarter revenues of $11.5 billion and pre-tax adjusted earnings of $1.5 billion. The medical care ratio (MCR) reached 79.8%, benefiting from lower flu and respiratory volumes and weather-related care deferrals.

Dennison noted the favorable impact of a higher proportion of individual exchange members enrolled in Bronze plans, which improves first-quarter MCR without affecting full-year projections.

Innovation and Technology Focus

Evanko detailed the company's expanding use of artificial intelligence across operations, including "agentic AI" in specialty operations and AI-enabled risk prediction models in Cigna Healthcare. The predictive high-cost claimants model has generated average savings of $2,000 per member per year among engaged customers by reducing unnecessary provider and emergency room visits.

Digital improvements have yielded operational benefits, with AI tools contributing to a 20% decrease in inbound calls for digitally eligible customers in the U.S. employer business and a 25% reduction for PBS members compared to two years prior.

Financial Position and Outlook

The company reported first-quarter operating cash flow of $1.1 billion, with most 2026 cash flow generation expected in the second half. The debt-to-capitalization ratio improved to 42.3% as of March 31, marking a 70 basis point improvement from year-end 2025.

For the second quarter, Dennison projects adjusted EPS to represent approximately 25% of the full-year outlook, with Cigna Healthcare expected to generate slightly above 60% of full-year earnings in the first half.